Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease
Updates Surg
.
2021 Oct;73(5):2029-2030.
doi: 10.1007/s13304-021-01008-4.
Epub 2021 Mar 3.
Authors
Gaetano Gallo
1
,
Maurizio Ronconi
2
,
Mario Trompetto
3
Affiliations
1
Department of Medical and Surgical Sciences, University of Catanzaro, Catanzaro, Italy. gallog@unicz.it.
2
Department of General Surgery, ASST-Spedali Civili-Gardone V.T Hospital, Brescia, Italy.
3
Department of Colorectal Surgery, S. Rita Clinic, Vercelli, Italy.
PMID:
33660166
PMCID:
PMC7927757
DOI:
10.1007/s13304-021-01008-4
No abstract available
Publication types
Letter
MeSH terms
Hemorrhoids* / therapy
Humans
Outpatients
Polidocanol / therapeutic use
Sclerosing Solutions
Sclerotherapy*
Treatment Outcome
Substances
Sclerosing Solutions
Polidocanol